U.S. hospitals reduced central line-associated bloodstream infections by 50 percent between 2008 and 2016, according to a recent CDC progress summary.
The CDC attributed the success of CLABSI reduction to "outstanding collaborative efforts among healthcare providers" backed by national prevention efforts led by the CDC, CMS and the Agency for Healthcare Research and Quality.
The CDC progress summary — first published in December of last year and updated Jan. 5 — features an analysis of healthcare-associated infection information reported to the National Healthcare Safety Network by acute care hospitals, as well as other CDC information sources.
Here are three more findings from the analysis.
1. Efforts to reduce catheter-associated urinary tract infections yielded little overall progress from 2009 to 2013. However, CAUTIs steadily declined from 2014 through 2016. Researchers identified an estimated 5 to 6 percent overall decline in CAUTIs between 2015 and 2016.
2. Methicillin-resistant Staphylococcus aureus rates have significantly declined since 2005, however progress has slowed in recent years. While MRSA declined by 13 percent from 2011 through 2014, declines dropped to 4 percent between 2012 and 2013.
3. Progress on reducing Clostridium difficile rates in the hospital setting has been intermittent and slow. Researchers reported an 8 percent decline in diff from 2010-11 through 2014.
More articles on infection control:
Student sickened with measles at Indiana University
CDC: Multistate E. coli outbreak continues, leafy greens likely source
Viewpoint: Global flu pandemic 'almost certainly on the horizon' — and the world is not prepared